First Trust Direct Indexing’s Neurocrine Biosciences NBIX Stock Holding History

First Trust Direct Indexing’s Portfolio NBIX Stock Details NBIX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$542K	Buy
2024 Q2	$612K	Buy
2024 Q1	$570K	Buy
2023 Q4	$421K	Buy
2023 Q3	$245K	Buy
2023 Q1	–	Sell
2022 Q4	$223K	Buy
2021 Q1	–	Sell
2020 Q4	$90K	Buy